"Hydroxyprogesterones" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Metabolites or derivatives of PROGESTERONE with hydroxyl group substitution at various sites.
Descriptor ID |
D006908
|
MeSH Number(s) |
D04.210.500.745.745.654.829.395 D06.472.334.851.687.750.478
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hydroxyprogesterones".
Below are MeSH descriptors whose meaning is more specific than "Hydroxyprogesterones".
This graph shows the total number of publications written about "Hydroxyprogesterones" by people in this website by year, and whether "Hydroxyprogesterones" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 1 | 2 |
2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hydroxyprogesterones" by people in Profiles.
-
Placental histology for targeted risk assessment of recurrent spontaneous preterm birth. Am J Obstet Gynecol. 2024 04; 230(4):452.e1-452.e11.
-
Studies of the nature of 17-hydroxyprogesterone hyperresonsiveness to gonadotropin-releasing hormone agonist challenge in functional ovarian hyperandrogenism. J Clin Endocrinol Metab. 1994 Dec; 79(6):1686-92.
-
Maturation of the normal pituitary-testicular axis, as assessed by gonadotropin-releasing hormone agonist challenge. J Clin Endocrinol Metab. 1994 Jun; 78(6):1336-40.
-
Ovarian steroidogenic responses to gonadotropin-releasing hormone agonist testing with nafarelin in hirsute women with adrenal responses to adrenocorticotropin suggestive of 3 beta-hydroxy-delta 5-steroid dehydrogenase deficiency. J Clin Endocrinol Metab. 1993 Feb; 76(2):450-5.
-
Detection of functional ovarian hyperandrogenism in women with androgen excess. N Engl J Med. 1992 Jul 16; 327(3):157-62.
-
Specificity of low dose fadrozole hydrochloride (CGS 16949A) as an aromatase inhibitor. J Clin Endocrinol Metab. 1991 Jul; 73(1):99-106.
-
Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome. N Engl J Med. 1989 Mar 02; 320(9):559-65.
-
Lipid cell tumor of the ovary in reference to adult-onset congenital adrenal hyperplasia and polycystic ovary syndrome. A case report. J Reprod Med. 1987 May; 32(5):363-9.
-
Prevention of premature labor by 17 alpha-hydroxyprogesterone caproate. Am J Obstet Gynecol. 1985 Mar 01; 151(5):574-7.
-
Female pseudohermaphroditism with adrenal cortical tumor in adulthood. J Endocrinol Invest. 1985 Feb; 8(1):63-5.